Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Ovarian Neoplasms 4Fallopian Tube Neoplasms 4Brenner Tumor 4Colorectal Neoplasms 3Colonic Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Tongue Neoplasms 1Stroke 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Lymphoid Interstitial Pneumonia 1Kidney Failure, Chronic 1Gliosarcoma 1Glioblastoma 1Gastrointestinal Stromal Tumors 1Endometrial Neoplasms 1Diabetes Mellitus 1Coronary Artery Disease 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Temozolomide 8Radiotherapy 6Procarbazine 4Radiation 3Lomustine 3Carmustine 3Dihematoporphyrin Ether 2sargramostim 1rindopepimut 1depatuxizumab mafodotin 1Vincristine 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiosurgery 1Photons 1O(6)-benzylguanine 1Neoadjuvant Therapy 1Methylphenidate 1Magnetic Resonance Spectroscopy 1Leflunomide 1Isotretinoin 1Immunoglobulin G 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fentanyl 1Donepezil 1Disulfides 1DNA Methylation 1Chemotherapy, Adjuvant 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Gliosarcoma × Disulfides × Clear all
NCT00884741 2019-07-24

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

National Cancer Institute (NCI)

Phase 3 Completed
637 enrolled 11 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡